These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 32810196)

  • 1. Untargeted high-resolution plasma metabolomic profiling predicts outcomes in patients with coronary artery disease.
    Mehta A; Liu C; Nayak A; Tahhan AS; Ko YA; Dhindsa DS; Kim JH; Hayek SS; Sperling LS; Mehta PK; Sun YV; Uppal K; Jones DP; Quyyumi AA
    PLoS One; 2020; 15(8):e0237579. PubMed ID: 32810196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline metabolomic profiles predict cardiovascular events in patients at risk for coronary artery disease.
    Shah SH; Sun JL; Stevens RD; Bain JR; Muehlbauer MJ; Pieper KS; Haynes C; Hauser ER; Kraus WE; Granger CB; Newgard CB; Califf RM; Newby LK
    Am Heart J; 2012 May; 163(5):844-850.e1. PubMed ID: 22607863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma Metabolome Predicts Aortic Stiffness and Future Risk of Coronary Artery Disease and Mortality After 23 Years of Follow-Up in the General Population.
    Ottosson F; Engström G; Orho-Melander M; Melander O; Nilsson PM; Johansson M
    J Am Heart Assoc; 2024 May; 13(9):e033442. PubMed ID: 38639368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of the severity of coronary artery disease with patients' metabolic profile- rationale, design and baseline patient characteristics of the CorLipid trial.
    Karagiannidis E; Sofidis G; Papazoglou AS; Deda O; Panteris E; Moysidis DV; Stalikas N; Kartas A; Papadopoulos A; Stefanopoulos L; Karvounis H; Gika H; Theodoridis G; Sianos G
    BMC Cardiovasc Disord; 2021 Feb; 21(1):79. PubMed ID: 33557756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of metabolomic markers and response to nutritional support: A secondary analysis of the EFFORT trial using an untargeted metabolomics approach.
    Struja T; Wolski W; Schapbach R; Mueller B; Laczko E; Schuetz P
    Clin Nutr; 2021 Sep; 40(9):5062-5070. PubMed ID: 34455264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted Metabolomic Profiling of Plasma and Survival in Heart Failure Patients.
    Lanfear DE; Gibbs JJ; Li J; She R; Petucci C; Culver JA; Tang WHW; Pinto YM; Williams LK; Sabbah HN; Gardell SJ
    JACC Heart Fail; 2017 Nov; 5(11):823-832. PubMed ID: 29096792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Untargeted metabolomic analysis of coronary artery disease patients with diastolic dysfunction show disturbed oxidative pathway.
    Fatima T; Hashmi S; Iqbal A; Siddiqui AJ; Sami SA; Basir N; Bokhari SS; Sharif H; Musharraf SG
    Metabolomics; 2019 Jun; 15(7):98. PubMed ID: 31236740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive Metabolomic Characterization of Coronary Artery Diseases.
    Fan Y; Li Y; Chen Y; Zhao YJ; Liu LW; Li J; Wang SL; Alolga RN; Yin Y; Wang XM; Zhao DS; Shen JH; Meng FQ; Zhou X; Xu H; He GP; Lai MD; Li P; Zhu W; Qi LW
    J Am Coll Cardiol; 2016 Sep; 68(12):1281-93. PubMed ID: 27634119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma metabolomic profiling in subclinical atherosclerosis: the Diabetes Heart Study.
    Chevli PA; Freedman BI; Hsu FC; Xu J; Rudock ME; Ma L; Parks JS; Palmer ND; Shapiro MD
    Cardiovasc Diabetol; 2021 Dec; 20(1):231. PubMed ID: 34876126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic Signatures in Coronary Artery Disease: Results from the BioHEART-CT Study.
    Vernon ST; Tang O; Kim T; Chan AS; Kott KA; Park J; Hansen T; Koay YC; Grieve SM; O'Sullivan JF; Yang JY; Figtree GA
    Cells; 2021 Apr; 10(5):. PubMed ID: 33922315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between NMR metabolomic signatures of healthy lifestyle and incident coronary artery disease.
    Fu Z; Liu Q; Liang J; Weng Z; Li W; Xu J; Zhang X; Xu C; Gu A
    Eur J Prev Cardiol; 2023 Feb; 30(3):243-253. PubMed ID: 36317303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of metabolic markers in coronary artery disease using an untargeted LC-MS based metabolomic approach.
    Basak T; Varshney S; Hamid Z; Ghosh S; Seth S; Sengupta S
    J Proteomics; 2015 Sep; 127(Pt A):169-77. PubMed ID: 25790721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive metabolic profiling of Parkinson's disease by liquid chromatography-mass spectrometry.
    Shao Y; Li T; Liu Z; Wang X; Xu X; Li S; Xu G; Le W
    Mol Neurodegener; 2021 Jan; 16(1):4. PubMed ID: 33485385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dimethylguanidino Valerate: A Lifestyle-Related Metabolite Associated With Future Coronary Artery Disease and Cardiovascular Mortality.
    Ottosson F; Ericson U; Almgren P; Smith E; Brunkwall L; Hellstrand S; Nilsson PM; Orho-Melander M; Fernandez C; Melander O
    J Am Heart Assoc; 2019 Oct; 8(19):e012846. PubMed ID: 31533499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolving biomarkers improve prediction of long-term mortality in patients with stable coronary artery disease: the BIO-VILCAD score.
    Kleber ME; Goliasch G; Grammer TB; Pilz S; Tomaschitz A; Silbernagel G; Maurer G; März W; Niessner A
    J Intern Med; 2014 Aug; 276(2):184-94. PubMed ID: 25184160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Copeptin predicts coronary artery disease cardiovascular and total mortality.
    Tasevska I; Enhörning S; Persson M; Nilsson PM; Melander O
    Heart; 2016 Jan; 102(2):127-32. PubMed ID: 26661323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Coronary Artery Disease and Metabolic Syndrome: Usefulness of Serum Metabolomics Approach.
    Jing Z; Liu L; Shi Y; Du Q; Zhang D; Zuo L; Du S; Sun Z; Zhang X
    Front Endocrinol (Lausanne); 2021; 12():692893. PubMed ID: 34630321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolomic Pattern Predicts Incident Coronary Heart Disease.
    Wang Z; Zhu C; Nambi V; Morrison AC; Folsom AR; Ballantyne CM; Boerwinkle E; Yu B
    Arterioscler Thromb Vasc Biol; 2019 Jul; 39(7):1475-1482. PubMed ID: 31092011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic profiling of umbilical cord blood in macrosomia.
    Sun H; Wang YC; Wang CC; Xu XX; Wang YH; Yan HT; Yang XJ
    Int J Obes (Lond); 2018 Apr; 42(4):679-685. PubMed ID: 29158542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma Ceramides.
    Meeusen JW; Donato LJ; Bryant SC; Baudhuin LM; Berger PB; Jaffe AS
    Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1933-1939. PubMed ID: 29903731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.